Small Pharma Reports Fiscal Third Quarter 2023 Highlights
Positive top-line results from Phase IIa trial of SPL026 in Major Depressive Disorder New SPL026 trials underway and screening commenced in the first...
Source: globenewswire.com
📰 Duration Psychedelic Program News
Duration Psychedelic Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Duration Psychedelic Program. Real-time updates on events, politics, business and more.